Search Medical Condition
Please enter condition
Please choose location

Nova Iguacu, Brazil Clinical Trials

A listing of Nova Iguacu, Brazil clinical trials actively recruiting patients volunteers.

RESULTS

Found (8) clinical trials

Evaluating the Use of Pitavastatin to Reduce the Risk of Cardiovascular Disease in HIV-Infected Adults

Currently, there are few strategies to prevent CVD in HIV-infected people, even though they are at high risk for developing CVD. Statin medications are used to lower cholesterol and may be effective at reducing the risk of CVD in people infected with HIV. The purpose of this study is to ...

Phase

3.2 miles

Learn More »

Study of a Candidate Clostridium Difficile Toxoid Vaccine in Subjects at Risk for C. Difficile Infection

The study is designed as an event-driven group sequential protocol with 4 interim analyses at defined information milestones and a final analysis when a specific number of clinical endpoints are reached. Subjects will be randomly assigned to receive either the candidate vaccine or a placebo that will be administered in ...

Phase

3.2 miles

Learn More »

A Cluster-Randomized Trial of DOTS vs DOTS Plus Active Case Finding

Tuberculosis (TB) continues to be a major cause of morbidity and mortality worldwide, particularly in developing countries. The World Health Organization (WHO) has estimated that one-third of the world's population is infected with Mycobacterium tuberculosis. Tuberculosis remains a major public health problem in Brazil, being the 15th highest TB burden ...

Phase N/A

7.47 miles

Learn More »

Pharmacokinetic Study of Antiretroviral Drugs and Related Drugs During and After Pregnancy

Pregnant women experience unique physiological changes that may result in clinically significant alterations in drug PKs. Unfortunately, there have been few clinical trials to study the PKs of ARV, TB, and hormonal contraceptive drugs in pregnant women. The development of appropriate dosing regimens for the HIV-infected pregnant woman is critical ...

Phase

7.92 miles

Learn More »

Safety and Pharmacokinetics of Raltegravir in HIV-1-Exposed Newborn Infants at Risk of Acquiring HIV-1 Infection

This study will evaluate the safety and PKs of RAL given to HIV-1-exposed newborn infants at risk of acquiring HIV-1 infection. The study also seeks to determine the appropriate dosing regimen of RAL that can be safely given to infants in the first 6 weeks of life. The study will ...

Phase

7.92 miles

Learn More »

Growth and Body Composition in Preterm Infants

OBJECTIVES GENERAL: Evaluate the growth and body composition of VLBW infants upon reaching the corresponding term gestational age (GA) and weight. SPECIFIC: A) Evaluate the longitudinal growth and body composition of VLBW infants from the first week of life and at the corresponding term GA and weight. B) Relate the ...

Phase N/A

9.44 miles

Learn More »

A Study to Evaluate the Efficacy and Safety of CC-220 in Subjects With Active Systemic Lupus Erythematosus

The study consists of four phases: - 4-week Screening Phase - 24-week placebo-controlled phase Subjects will receive either 0.45 mg QD, 0.3 mg QD, 0.15 mg QD or placebo for the first 24 weeks of treatment. - 28-week active treatment phase At Week 24, all subjects on placebo will be ...

Phase

9.44 miles

Learn More »